These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27326179)

  • 21. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
    Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
    Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application and efficacy of the adjustment on left ventricular electrical delay and the distance between right and left ventricular pacing polar in optimizing the left ventricular pacing polar].
    Yan XL; Liang YC; Yu HB; Xu BG; Gao Y; Liu R; Xu GQ; Wu M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):669-674. PubMed ID: 32847323
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute and Long-Term Outcomes of Transvenous Cardiac Pacing Device Implantation in Patients With Congenital Heart Disease.
    Takeuchi D; Toyohara K; Yagishita D; Yazaki K; Higuchi S; Ejima K; Shoda M; Hagiwara N
    Circ Rep; 2019 Sep; 1(10):445-455. PubMed ID: 33693082
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function.
    Looi KL; Gajendragadkar PR; Khan FZ; Elsik M; Begley DA; Fynn SP; Grace AA; Heck PM; Virdee M; Agarwal S
    Heart; 2014 May; 100(10):794-9. PubMed ID: 24691411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.
    Gasparini M; Galimberti P; Regoli F; Ceriotti C; Bonadies M
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1279-83. PubMed ID: 16403056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.
    Barra S; Providência R; Boveda S; Duehmke R; Narayanan K; Chow AW; Piot O; Klug D; Defaye P; Gras D; Deharo JC; Milliez P; Da Costa A; Mondoly P; Gonzalez-Panizo J; Leclercq C; Heck P; Virdee M; Sadoul N; Le Heuzey JY; Marijon E
    Heart; 2018 Sep; 104(18):1529-1535. PubMed ID: 29540431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme.
    Nowak B; Tasche K; Barnewold L; Heller G; Schmidt B; Bordignon S; Chun KR; Fürnkranz A; Mehta RH
    Europace; 2015 May; 17(5):787-93. PubMed ID: 25733549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators Groupe de rythmologie et stimulation cardiaque de la Société française de cardiologie et Société française de gériatrie et gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):239-64. PubMed ID: 27651007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems.
    Aggarwal RK; Connelly DT; Ray SG; Ball J; Charles RG
    Br Heart J; 1995 Jun; 73(6):571-5. PubMed ID: 7626359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiology Catheter-Facilitated coronary sinus cannulation and implantation of cardiac resynchronization therapy systems.
    Manolis AS; Koulouris S; Tsiachris D
    Hellenic J Cardiol; 2018; 59(1):26-33. PubMed ID: 28778735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013].
    Proclemer A; Zecchin M; D'Onofrio A; Botto GL; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):638-50. PubMed ID: 25424143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy in congestive heart failure: Ready for prime time?
    Manolis AS
    Heart Rhythm; 2004 Sep; 1(3):355-63. PubMed ID: 15851184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients.
    Auricchio A; Delnoy PP; Regoli F; Seifert M; Markou T; Butter C;
    Europace; 2013 Aug; 15(8):1191-7. PubMed ID: 23703364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.